Pakistan will be manufacturing the anti viral drug Remdsivir within two months according to Special Assistant on National Health Services Dr Zafar Mirza. The drug will also be available for COVID-19 patients in Pakistan. Dr Mirza said that five companies in the world had been granted the license to manufacture the drug, Pakistani company being one of them.
He said that the medicine will be available for COVID-19 patients in Pakistan after it is registered within six to eight weeks and manufactured in the country. American company Gilead has manufactured this drug and it has proven effective in treating coronavirus patients.
Source: Daily Times
Inflics provides it readers the information that they need in concise and short articles, making information and news more accessible to everyone.